Citation: T. Bourcier et P. Libby, HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells, ART THROM V, 20(2), 2000, pp. 556-562
Authors:
Schonbeck, U
Sukhova, GK
Shimizu, K
Mach, F
Libby, P
Citation: U. Schonbeck et al., Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice, P NAS US, 97(13), 2000, pp. 7458-7463
Authors:
Shimizu, K
Schonbeck, U
Mach, F
Libby, P
Mitchell, RN
Citation: K. Shimizu et al., Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis, J IMMUNOL, 165(6), 2000, pp. 3506-3518
Authors:
Marx, N
Mach, F
Sauty, A
Leung, JH
Sarafi, MN
Ransohoff, RM
Libby, P
Plutzky, J
Luster, AD
Citation: N. Marx et al., Peroxisome proliferator-activated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells, J IMMUNOL, 164(12), 2000, pp. 6503-6508
Authors:
Kol, A
Lichtman, AH
Finberg, RW
Libby, P
Kurt-Jones, EA
Citation: A. Kol et al., Cutting edge: Heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells, J IMMUNOL, 164(1), 2000, pp. 13-17
Authors:
Young, JL
Sukhova, GK
Foster, D
Kisiel, W
Libby, P
Schonbeck, U
Citation: Jl. Young et al., The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1 beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells, J EXP MED, 191(9), 2000, pp. 1535-1544
Authors:
Ducharme, A
Frantz, S
Aikawa, M
Rabkin, E
Lindsey, M
Rohde, LE
Schoen, FJ
Kelly, RA
Werb, Z
Libby, P
Lee, RT
Citation: A. Ducharme et al., Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction, J CLIN INV, 106(1), 2000, pp. 55-62
Authors:
Fabunmi, RP
Moore, KJ
Libby, P
Freeman, MW
Citation: Rp. Fabunmi et al., Stromelysin-1 (MMP-3) expression driven by a macrophage-specific promoter results in reduced viability in transgenic mice, ATHEROSCLER, 148(2), 2000, pp. 375-386
Authors:
Abi-Younes, S
Sauty, A
Mach, F
Sukhova, GK
Libby, P
Luster, AD
Citation: S. Abi-younes et al., The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques, CIRCUL RES, 86(2), 2000, pp. 131-138
Citation: Kj. Haley et al., Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis -Using genomic technology to identify a potential novel pathway of vascularinflammation, CIRCULATION, 102(18), 2000, pp. 2185-2189
Authors:
Furukawa, Y
Mandelbrot, DA
Libby, P
Sharpe, AH
Mitchell, RN
Citation: Y. Furukawa et al., Association of B7-1 co-stimulation with the development of graft arterial disease - Studies using mice lacking B7-1, B7-2, or B7-1/B7-2, AM J PATH, 157(2), 2000, pp. 473-484
Citation: A. Melian et al., CD1 expression and the nature of CD1-expressing cells in human atherosclerotic plaques - Author's reply, AM J PATH, 156(4), 2000, pp. 1477-1478